CHCT Community Healthcare Trust (CHCT) Insider Trading, Ownership & Congress Trades
Real Estate · Real estate investment trusts · CIK 0001631569
C-suite buying · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
89
13F, latest reported quarter
What the filings say about CHCT
Insiders, 180 days
+$273.0K net bought
2 buyers
Community Healthcare Trust insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Community Healthcare Trust Inc insiders bought a net $273.0K of stock across 16 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on May 13, 2025.
- -5.0% median (-5.0% mean) 90-day return after 2 previous buys.
- The trade is 1.8% of the 557,262 shares held after it.
- 1 other insider bought within 30 days.
- 89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO and President Dupuy David H. bought about $151.3K of CHCT on Aug 14, 2026, the largest insider purchase at the company since 2025; 1 other insider bought within 30 days and 89 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Aug 5, 2024.
- The trade is 7.7% of the 103,702 shares held after it.
- 1 other insider bought within 30 days.
- 89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hensley Robert Z bought about $121.7K of CHCT on Aug 11, 2026, the largest insider purchase at the company since 2025; 1 other insider bought within 30 days and 89 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (3 buys, 1 sale), the last on Apr 30, 2025.
- +1.6% median (+2.7% mean) 90-day return after 3 previous buys.
- The trade is 10.6% of the 37,635 shares held after it.
- No other insider bought within 30 days.
- 89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cotman Cathrine bought about $58.6K of CHCT on Nov 4, 2025; 89 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Sep 9, 2024.
- +1.6% median (+6.5% mean) 90-day return after 3 previous buys.
- The trade is 13.3% of the 88,502 shares held after it.
- 2 other insiders bought within 30 days.
- 89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Van Horn R. Lawrence bought about $193.4K of CHCT on May 28, 2025; 2 other insiders bought within 30 days and 89 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Aug 5, 2024.
- The trade is 2.2% of the 458,500 shares held after it.
- 2 other insiders bought within 30 days.
- 89 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO and President Dupuy David H. bought about $162.3K of CHCT on May 13, 2025; 2 other insiders bought within 30 days and 89 funds added in the latest 13F quarter.16 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$273.0K over 180 days
+$273.0K over 90 days
more than 81% of Real Estate
Congress
no House purchase disclosed in the last 12 months
Funds
89 funds bought in last quarter
below 66% of Real Estate
Revenue
+4.7% year over year
more than 52% of Real Estate
Margin
4.2% net margin
below 56% of Real Estate
Buybacks
no share repurchases reported
Short interest
3.4% of the float short (float per yahoo 2026-10-26) · 2.1 days to cover · settled 2026-09-30
below 59% of Real Estate
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CHCT
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+0.6%12M
Insider buy
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CHCT: institutional holders (13F)
13F holdings, latest reported quarter
2,637,919 sh
$48.2M
2,057,305 sh
$37.6M
1,458,228 sh
$26.7M
1,183,409 sh
$21.6M
1,181,281 sh
$21.6M
Congress trades in CHCT
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CHCT planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CHCT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Invesco KBW Premium Yield Equity REIT ETF
$13.4M position · as of 2026-05-31
4.6%
ALPS REIT Dividend Dogs ETF
$238.4K position · as of 2026-05-31
2.1%
Global X SuperDividend U.S. ETF
$15.6M position · as of 2026-07-31
2.0%
Davis Real Estate Fund
$2.3M position · as of 2026-06-30
1.8%
Cambria Global Real Estate ETF
$915.4K position · as of 2026-07-31
1.4%
Hoya Capital High Dividend Yield ETF
$1.4M position · as of 2026-05-31
1.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · David H. Dupuy,
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.4M
$2.4M
$2.9M
-51%
+27%
2024
$3.1M
$1.8M
$1.9M
-49%
+24%
2022
$4.5M
$1.7M
$2.3M
-17%
+6%
2021
$4.8M
$5.5M
$2.2M
+4%
+41%
2020
$3.7M
$5.1M
$2.2M
+14%
-5%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $273.0K bought by insiders over 180 days, 89 funds added last quarter. Each figure is a federal filing, dated the day it went public.
CHCT financials
Revenue growth
+4.7%
XBRL, annual
Net margin
4.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$124.8M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CHCT
| FY Dec 2025 | $121.2M |
| FY Dec 2024 | $115.8M |
| FY Dec 2023 | $112.8M |
| FY Dec 2022 | $97.7M |
| FY Dec 2021 | $90.6M |
| Jun 2026 | $31.2M |
| Mar 2026 | $31.5M |
| Dec 2025 | $30.9M |
| Sep 2025 | $31.1M |
| Jun 2025 | $29.1M |
| Mar 2025 | $30.1M |
| Dec 2024 | $29.3M |
| Sep 2024 | $29.6M |
At each fiscal year end
Single quarter
Net margin, TTM
+16.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CHCT
| FY Dec 2025 | +4.2% |
| FY Dec 2024 | -2.7% |
| FY Dec 2023 | +6.8% |
| FY Dec 2022 | +22.5% |
| FY Dec 2021 | +24.8% |
| Jun 2026 | +7.6% |
| Mar 2026 | +8.1% |
| Dec 2025 | +46.6% |
| Sep 2025 | +5.3% |
| Jun 2025 | -43.2% |
| Mar 2025 | +5.3% |
| Dec 2024 | +6.3% |
| Sep 2024 | +5.9% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$38.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CHCT
| FY Dec 2025 | $35.9M |
| FY Dec 2024 | $34.2M |
| FY Dec 2023 | $42.4M |
| FY Dec 2022 | $49.9M |
| FY Dec 2021 | $49.1M |
| Jun 2026 | $13.3M |
| Mar 2026 | $8.8M |
| Dec 2025 | $9.0M |
| Sep 2025 | $7.6M |
| Jun 2025 | $9.6M |
| Mar 2025 | $9.7M |
| Dec 2024 | $10.5M |
| Sep 2024 | $6.7M |
At each fiscal year end
Single quarter
Debt to equity
1.35x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity CHCT
| FY Dec 2025 | 1.24x |
| FY Dec 2024 | 1.02x |
| FY Dec 2023 | 0.79x |
| FY Dec 2022 | 0.71x |
| FY Dec 2021 | 0.57x |
| Jun 2026 | 1.35x |
| Mar 2026 | 1.33x |
| Dec 2025 | 1.24x |
| Sep 2025 | 1.24x |
| Jun 2025 | 1.14x |
| Mar 2025 | 1.08x |
| Dec 2024 | 1.02x |
| Sep 2024 | 0.99x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.11x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt CHCT
| FY Dec 2025 | 0.11x |
| FY Dec 2024 | 0.12x |
| FY Dec 2023 | 0.15x |
| FY Dec 2022 | 0.17x |
| FY Dec 2021 | 0.21x |
| Jun 2026 | 0.11x |
| Mar 2026 | 0.10x |
| Dec 2025 | 0.11x |
| Sep 2025 | 0.11x |
| Jun 2025 | 0.12x |
| Mar 2025 | 0.12x |
| Dec 2024 | 0.12x |
| Sep 2024 | 0.12x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+4.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CHCT
| FY Dec 2025 | +1.1% |
| FY Dec 2024 | -0.6% |
| FY Dec 2023 | +1.5% |
| FY Dec 2022 | +4.6% |
| FY Dec 2021 | +5.0% |
| Jun 2026 | +4.9% |
| Mar 2026 | +1.4% |
| Dec 2025 | +1.1% |
| Sep 2025 | -1.7% |
| Jun 2025 | -1.6% |
| Mar 2025 | -1.1% |
| Dec 2024 | -0.6% |
| Sep 2024 | -0.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CHCT
| FY Dec 2025 | +0.5% |
| FY Dec 2024 | -0.3% |
| FY Dec 2023 | +0.8% |
| FY Dec 2022 | +2.7% |
| FY Dec 2021 | +3.2% |
| Jun 2026 | +2.1% |
| Mar 2026 | +0.6% |
| Dec 2025 | +0.5% |
| Sep 2025 | -0.8% |
| Jun 2025 | -0.8% |
| Mar 2025 | -0.5% |
| Dec 2024 | -0.3% |
| Sep 2024 | -0.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CHCT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CHCT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
19.25x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CHCT
| FY Dec 2025 | 234.57x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 148.00x |
| FY Dec 2022 | 43.66x |
| FY Dec 2021 | 54.33x |
| Jun 2026 | 27.28x |
| Mar 2026 | 144.45x |
| Dec 2025 | 234.57x |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$926.3M
market value at close 2026-10-26 on 2026-07-28 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value CHCT
| FY Dec 2025 | $996.4M |
| FY Dec 2024 | $1.0B |
| FY Dec 2023 | $1.1B |
| FY Dec 2022 | $1.2B |
| FY Dec 2021 | $1.4B |
| Jun 2026 | $1.1B |
| Mar 2026 | $1.0B |
| Dec 2025 | $996.4M |
| Sep 2025 | $960.8M |
| Jun 2025 | $966.5M |
| Mar 2025 | $1.0B |
| Dec 2024 | $1.0B |
| Sep 2024 | $980.1M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+10.5%
TTM free cash flow over market value at close 2026-10-26
FCF yield CHCT
| FY Dec 2025 | +7.7% |
| FY Dec 2024 | +6.3% |
| FY Dec 2023 | +5.8% |
| FY Dec 2022 | +5.5% |
| FY Dec 2021 | +4.2% |
| Jun 2026 | +7.4% |
| Mar 2026 | +7.7% |
| Dec 2025 | +7.7% |
| Sep 2025 | +8.6% |
| Jun 2025 | +7.7% |
| Mar 2025 | +7.1% |
| Dec 2024 | +6.3% |
| Sep 2024 | +6.0% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing CHCT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 6.21x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $121.2M | $115.8M | $112.8M | $97.7M |
| Net income | $5.1M | -$3.2M | $7.7M | $22.0M |
| EPS (diluted) | 0.08 | -0.23 | 0.20 | 0.81 |
| Operating cash flow | $56.4M | $58.9M | $61.4M | $60.3M |
| Cash | $3.3M | $4.4M | $3.5M | $11.2M |
| Long-term debt | $532.2M | $486.0M | $403.3M | $353.0M |
| Dividends paid | $53.7M | $51.7M | $48.1M | $44.5M |
SEC XBRL, fiscal years, as known on 2026-10-28
CHCT Stock Sonar score 6/7 axes
Find similar shapesCompareCHCT ranks highest on insider conviction (79th percentile) and risk and compliance (76th), and lowest on institutional and government (34th), among Real Estate peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CHCT filings, in plain words
Are Community Healthcare Trust insiders buying or selling CHCT?
In the 180 days to 2026-10-28, Community Healthcare Trust insiders were net buyers, a net $273.0K across purchases and sales reported on Form 4, by 2 buyers.
Read the full summary
In the 180 days to 2026-10-28, Community Healthcare Trust insiders were net buyers of CHCT, a net $273.0K across purchases and sales reported on Form 4 by 2 buyers. 2 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
